selexipag
(Selexipag)Zydus Lifesciences Limited
Usage: Selexipag tablets are indicated for treating pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce hospitalization risk. Effectiveness is established for patients with WHO Functional Class II-III symptoms, including idiopathic, heritable, and PAH associated with connective tissue disease or congenital heart defects.